MedPath

Epileptogenic Zone's Cartography by Quantification of EEG's Signal and Intracerebral Stimulation.

Not Applicable
Conditions
Epilepsy
Registration Number
NCT02844374
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Epilepsy is a devastating chronic disease due to multiple causes that affect close to 50% of the world's population.

Although effective, epilepsy surgery fails in many cases, the percentage of patients free from crisis on a long term (≥ 5 years) varies from 27% to 66% according to the kind of epilepsy.

It is in this context that EPISTIM is interesting, and its aims isb a better electrophysiology delimiting of cortical networks that imply the genesis of seizures with the aim to improove surgery results.

This study will rely on the intracerebral records and on corticales electrical stimulation as they are currently routinely used by epileptic patients candidates for surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Connectivity mapsup to 10 min

Connectivity maps : calculated for each site stimulated at low-frequency.

Visual analysisup to one hour

Visual analysis : in order to define the level of cortical resections.

Epileptogenic mapsup to 10 min

Epileptogenic maps : calculated for each crisis and for all crisis in general.

MRIup to one hour

Post-operative evaluation : in order to assess the extent of resection. MRI : 3D-T1

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UniversityHospitalGrenoble

🇫🇷

La Tronche, France

UniversityHospitalGrenoble
🇫🇷La Tronche, France
Philippe Kahane, Professor
Contact
04.76.76.54.48
philippe.kahane@ujf-grenoble.fr
Lorella Minotti
Contact
0476765448
Lminotti@chu-grenoble.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.